Hi Mike, unfortunately none of the “remaining” drugs (Xtandi, Apalutamide and Provenge) are available to me here in Australia. Well they are available but not via the Pharmaceutical Benefits Scheme (PBS) a government financed subsidy scheme which means I pay $6.30 per subscript
ion rather than full price. They are all prohibitively expensive.
Incidentally I am surprised your Onco is proposing Apalutamide as I thought that even in the US that was only available for non metastatic patients, and you have indicated several mets. No matter, if you can get it, then go for it.
PS Should explain Xtandi is approved on the PBS, but not if Zytiga has already been prescribed.
Post Edited (Chask) : 3/4/2019 5:51:38 PM (GMT-7)